Search Results
Jul 13, 2026, 08:00 ET Eliud Kipchoge'nin Katkılarıyla Geliştirilen HUAWEI WATCH GT Runner 2 Brezilya'da Koşucularla Buluşuyor
Bu yolculuğun ikinci durağı, Kipchoge'yi kendisi için özel bir anlam taşıyan Brezilya'ya götürüyor. Efsanevi atlet, 12 Temmuz'da NB42K Porto Alegre etkinliği kapsamında Porto Alegre'de koştu. Kipchoge, ilk Olimpiyat altın madalyasını 2016 Rio Olimpiyatları'nda Brezilya'da kazanmıştı.
More news about: HUAWEI
Jul 13, 2026, 08:00 ET From the Lab to the Road: How Training Science Arrives in Brazil with the HUAWEI WATCH GT Runner 2
more active lifestyles around the world.The second stop of the tour brings him back to a special place: Porto Alegre, on July 12, during the NB42K Porto Alegre. It was on Brazilian soil that Kipchoge won his first Olympic gold medal at the 2016 Summer Olympics, making this return particularly symbolic.
More news about: HUAWEI
Jul 13, 2026, 08:00 ET Van het laboratorium naar de weg: Hoe Training Science arriveert in Brazilië met de HUAWEI WATCH GT Runner 2
over de hele wereld te inspireren.De tweede stop van de tour brengt hem terug naar een speciale plek: Porto Alegre, op 12 juli, tijdens de NB42K Porto Alegre. Het was op Braziliaanse bodem dat Kipchoge zijn eerste Olympische gouden medaille won op de Olympische Zomerspelen van 2016, waardoor deze
More news about: HUAWEI
Jul 13, 2026, 08:00 ET From the Lab to the Road: How Training Science Arrives in Brazil with the HUAWEI WATCH GT Runner 2
more active lifestyles around the world.The second stop of the tour brings him back to a special place: Porto Alegre, on July 12, during the NB42K Porto Alegre. It was on Brazilian soil that Kipchoge won his first Olympic gold medal at the 2016 Summer Olympics, making this return particularly symbolic.
More news about: HUAWEI
Jul 13, 2026, 08:00 ET Pelican Energy Partners Announces Acquisition of Veridiam, a Precision Manufacturer of Fuel Channels for the Nuclear Industry and Other Proprietary Components Across Multiple Industries
July 13, 2026 /PRNewswire/ -- Pelican Energy Partners ("Pelican") is pleased to announce the acquisition of Veridiam, LLC (f/k/a Veridiam, Inc.) ("Veridiam") from an affiliate of Equity Group Investments ("EGI"). Headquartered in El Cajon, California, Veridiam is a strategic
More news about: Pelican Energy Partners
Jul 13, 2026, 08:00 ET Payoneer Expands India Presence with New Gurugram Innovation Hub
outcome of any known and/or unknown legal or regulatory proceedings; and (6) other risks and uncertainties set forth in Payoneer's Annual Report on Form 10-K for the period ended December 31, 2025 and future reports that Payoneer may file with the SEC from time to time. Nothing in this press release should
More news about: Payoneer
Jul 13, 2026, 08:00 ET Third Coast Bancshares, Inc. Announces Sale of Third Coast Commercial Capital, Inc. Assets
results to differ materially from those described in the forward-looking statements, please see the risk factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the U.S. Securities and Exchange Commission (the "SEC"), and our other filings with the SEC.
More news about: Third Coast Bancshares
Jul 13, 2026, 08:00 ET Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year
reports to the Securities and Exchange Commission, including, without limitation the risk factors discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, and subsequent quarterly reports on Form 10-Q. Any forward-looking statements made by the Company in this release
More news about: Astrana Health, Inc.
Jul 13, 2026, 08:00 ET AWH Announces Reverse Stock Split Vote in Support of Planned U.S. Exchange Uplisting
herein. Such factors include, without limitation, the risks and uncertainties identified in the Company's most recently filed Annual Report on Form 10-K, as updated in subsequently filed Quarterly Reports on Form 10-Q, as applicable, and in the Company's other reports and filings with the applicable Canadian
More news about: Ascend Wellness Holdings, Inc.
Jul 13, 2026, 07:59 ET IQST - IQSTEL Builds Corporate Platform to Enhance Financial Transparency, Positioning the Company for Transformational M&A and Digital Services Expansion
holding company structure became effective on July 2, 2026, and the Company publicly disclosed the completed transaction through a Current Report on Form 8-K that has already been filed.The transaction is solely an internal corporate initiative to create a new financial platform and does not change
More news about: iQSTEL
Jul 13, 2026, 07:57 ET I-ON Digital Outlines Growth Roadmap: Positioning Banks for the Digital Asset Era While Putting Gold to Work
actual results may differ materially. Investors should review the company's filings with the SEC, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, for a discussion of risk factors. I-ON undertakes no obligation to update forward-looking statements except as required
More news about: I-ON Digital Corp. (OTCQB: IONI)
Jul 13, 2026, 07:30 ET Keenova Announces Publication of New Acthar® Gel (repository corticotropin injection) Manuscript in the Journal of Comparative Effectiveness Research
and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Keenova's most recent Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q, filed with the Securities and Exchange Commission (SEC) and other filings with the SEC, all of which are
More news about: Keenova Therapeutics
Jul 13, 2026, 07:12 ET ESGFIRE Publishes Pre-Listing Analysis on Alchemy Labs Inc. (TSXV: ALCH) Ahead of TSX Venture Exchange Debut
we treat it as such. On the allied side, the Company reports a $450k NRE contract with a US defence prime, SOCOM Tier 1 and Tier 2 engagements, and selection into NATO's DIANA 2026 cohort (Company: top 3.7% of applicants) with $330k of associated funding. Government and prime validation of this kind
More news about: ESGFIRE
Jul 13, 2026, 07:00 ET Armata Pharmaceuticals Receives Agreement from FDA on Initial Pediatric Study Plan for AP-SA02 for the Treatment of Complicated Staphylococcus aureus Bacteremia
elsewhere in Armata's filings and reports with the U.S. Securities and Exchange Commission (the "SEC"), including in Armata's Annual Report on Form 10-K, filed with the SEC on March 25, 2026, and in its subsequent filings with the SEC.Armata expressly disclaims any obligation or undertaking to
More news about: Armata Pharmaceuticals, Inc.
Jul 13, 2026, 06:59 ET Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata
terms or at all, and such other risks and uncertainties identified in the "Risk Factors" section of Q32 Bio's most recently Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC, and subsequent quarterly reports. Except as required by applicable securities laws, Q32 Bio
More news about: Q32 Bio
Jul 13, 2026, 06:50 ET Resideo To Present Strategy and Financial Framework as Pure-Play Building Technologies Company at Investor Day
other risks described under the headings "Risk Factors" and "Cautionary Statement Concerning Forward-Looking Statements" in our Annual Report on Form 10-K for the year ended December 31, 2025 and other periodic reports.All statements, other than statements of fact, that address activities, events
More news about: Resideo Technologies, Inc.
Jul 13, 2026, 06:45 ET Lazard Reports June 2026 Assets Under Management
include, but are not limited to, those discussed in our Annual Report on Form 10-K under Item 1A "Risk Factors," and also discussed from time to time in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including the following:Adverse general economic conditions
More news about: Lazard
Jul 13, 2026, 06:45 ET Brand Engagement Network Expands Cataneo into U.S. Market Following Acquisition
described in the Company's filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and subsequent filings. BEN undertakes no obligation to update any forward-looking statements except as required by law.
More news about: Brand Engagement Network, Inc. (BEN)
Jul 13, 2026, 06:00 ET OB Streem, an H.I.G. Capital Portfolio Company, Completes the Acquisition of Med Frigo
[email protected]. Capital10 Grosvenor Street2nd FloorLondon W1K 4QBP: +44 (0) 207 318 5700
More news about: H.I.G. Capital
Jul 13, 2026, 06:00 ET OB Streem, an H.I.G. Capital Portfolio Company, Completes the Acquisition of Med Frigo
[email protected]. Capital10 Grosvenor Street2nd FloorLondon W1K 4QBP: +44 (0) 207 318 5700
More news about: H.I.G. Capital
Jul 13, 2026, 06:00 ET OB Streem, een portefeuilleonderneming van H.I.G. Capital, voltooit de overname van Med Frigo
[email protected]. Capital10 Grosvenor Street2nd FloorLonden W1K 4QBTel.: +44 (0) 207 318 5700
More news about: H.I.G. Capital
Jul 13, 2026, 06:00 ET OB Streem, ein Portfoliounternehmen von H.I.G. Capital, schließt die Übernahme von Med Frigo ab
[email protected]. Capital10 Grosvenor Street2. StockLondon W1K 4QBTel.: +44 (0) 207 318 5700
More news about: H.I.G. Capital
Jul 13, 2026, 06:00 ET OB Streem, une société du portefeuille de H.I.G. Capital, finalise l'acquisition de Med Frigo
[email protected]. Capital10 Grosvenor Street2nd FloorLondon W1K 4QBP : +44 (0) 207 318 5700
More news about: H.I.G. Capital
Jul 13, 2026, 04:00 ET Eisai Presents Latest Findings Showed Etalanetug Reduced Alzheimer's Disease Tau Tangle-Specific Plasma Biomarker MTBR-tau243 at Alzheimer's Association International Conference® (AAIC®) 2026
https://doi.org/10.1002/alz.13859Horie, K. et al. Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's disease. Nat Med 31, 2044–2053 (2025).
More news about: Eisai Inc.
Jul 13, 2026, 01:31 ET Former INTERPOL President H.E. Ahmed Naser Al-Raisi Joins Robo.ai as Chairman of Neurovia AI to Build Trusted, Sovereign AI Infrastructure in the UAE and GCC Region
refer to the Company's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F and current reports on Form 6-K. Except as required by law, the Company undertakes no obligation to update any forward-looking statements.Media ContactNeurovia
More news about: Robo.ai Inc.; Neurovia AI